Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia

Kenji Umeki, Kohsaku Komiya, Issei Tokimatsu, Masaru Ando, Kazufumi Hiramatsu, Jun-ichi Kadota
European Respiratory Journal 2015 46: PA2574; DOI: 10.1183/13993003.congress-2015.PA2574
Kenji Umeki
1Respiratory and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohsaku Komiya
1Respiratory and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Issei Tokimatsu
2Infection Control Team, Kobe University Hospital, Kobe, Hyogo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaru Ando
1Respiratory and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazufumi Hiramatsu
1Respiratory and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-ichi Kadota
1Respiratory and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background and aim: In 2011, the Japanese Respiratory Society proposed the guideline for Nursing- and healthcare-associated pneumonia (NHCAP) (Kohno S, et al. Respir Investig 2013; 51:103-126), which is a modification of Healthcare-associated pneumonia guidelines of the US. However, it is still unclear what are the proper treatments for NHCAP. Though NHCAP patients are recognized as having drug resistant pathogens, the mortalities does not depend on the proper antibiotics for them but on the situations of the patients. To evaluate the contribution of the broad-spectrum antibiotics for high-risk NHCAP, we retrospectively examined the admitted NHCAP patients.

Methods: We defined the “high-risk patients” as those in severe or very severe classification, or with PS 3 or 4. The criteria for NHCAP were as described in NHCAP guideline. Out of 864 hospitalized pneumonia patients, we retrospectively investigated the 209 patients who meet the NHCAP criteria and also the high-risk definition. Then we divided the high-risk patients into to following two groups. In Narrow group, patients were treated with narrow-spectrum antibiotics and patients treated with broad-spectrum antibiotics were in Broad group. Survival was analyzed using Kaplan-Meier curves and log-rank test.

Results: The numbers of the patients were 164 in Narrow group and 63 in Broad group. The 30-day mortalities were 15.1% and 25.4%, respectively. Although the difference was not significant, the survival rate of Narrow group tended to be higher than that of Broad group (p = 0.074).

Conclusions: We demonstrated that broad-spectrum antibiotics could not always improve the prognoses of the high-risk NHCAP patients.

  • Pneumonia
  • Elderly
  • Treatments
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia
Kenji Umeki, Kohsaku Komiya, Issei Tokimatsu, Masaru Ando, Kazufumi Hiramatsu, Jun-ichi Kadota
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2574; DOI: 10.1183/13993003.congress-2015.PA2574

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia
Kenji Umeki, Kohsaku Komiya, Issei Tokimatsu, Masaru Ando, Kazufumi Hiramatsu, Jun-ichi Kadota
European Respiratory Journal Sep 2015, 46 (suppl 59) PA2574; DOI: 10.1183/13993003.congress-2015.PA2574
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
  • Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
  • Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society